Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Capital Leases (2016)

Historic Capital Leases for Arrowhead Pharmaceuticals (ARWR) over the last 6 years, with Q2 2016 value amounting to $378862.0.

  • Arrowhead Pharmaceuticals' Capital Leases fell 3638.09% to $378862.0 in Q2 2016 from the same period last year, while for Jun 2016 it was $378862.0, marking a year-over-year decrease of 3638.09%. This contributed to the annual value of $540792.0 for FY2015, which is 2868.74% down from last year.
  • Arrowhead Pharmaceuticals' Capital Leases amounted to $378862.0 in Q2 2016, which was down 3638.09% from $430665.0 recorded in Q1 2016.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Capital Leases peaked at $1.4 million during Q1 2012, and registered a low of $378862.0 during Q2 2016.
  • Its 5-year average for Capital Leases is $878776.7, with a median of $838973.0 in 2014.
  • Its Capital Leases has fluctuated over the past 5 years, first crashed by 1499.8% in 2012, then plummeted by 3638.09% in 2016.
  • Arrowhead Pharmaceuticals' Capital Leases (Quarter) stood at $1.2 million in 2012, then decreased by 18.03% to $1.0 million in 2013, then dropped by 29.93% to $705173.0 in 2014, then plummeted by 31.1% to $485842.0 in 2015, then decreased by 22.02% to $378862.0 in 2016.
  • Its Capital Leases stands at $378862.0 for Q2 2016, versus $430665.0 for Q1 2016 and $485842.0 for Q4 2015.